Data / Research funding / Massachusetts / Schepens Eye Research Institute
Schepens Eye Research Institute: 64 NIH awards ($71.6M), fiscal years 2021 to 2026
Schepens Eye Research Institute in Boston, MA is funded under 64 NIH awards ($71.6M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- XQQJEDK7JC21
- State
- Massachusetts
Awards
64 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Core Grant for Vision Research | NIH | National Eye Institute | 2021 to 2025 | $4,521,759 | August 1, 1997 | August 31, 2027 | D'AMORE, PATRICIA ANN | reporter.nih.gov |
| Innate and Adaptive Immunity in the Pathogenesis of Glaucoma | NIH | National Eye Institute | 2021 to 2025 | $4,329,067 | September 1, 2021 | June 30, 2026 | CHEN, DONG FENG | reporter.nih.gov |
| Ocular Immune Regulation by Mesenchymal Stem Cells | NIH | National Eye Institute | 2021 to 2025 | $3,542,949 | April 1, 2015 | September 14, 2028 | CHAUHAN, SUNIL K | reporter.nih.gov |
| Mechanisms of Sensitization in High Risk Corneal Grafts | NIH | National Eye Institute | 2021 to 2025 | $3,336,083 | August 1, 2000 | July 31, 2027 | DANA, REZA | reporter.nih.gov |
| Scanning and Detection at Intersections | NIH | National Eye Institute | 2021 to 2024 | $2,936,935 | September 30, 2015 | August 31, 2025 | BOWERS, ALEXANDRA RAE | reporter.nih.gov |
| Visual Field Expansion Through Innovative Multi-periscopic Prism Design (AD) | NIH | National Eye Institute | 2021 to 2024 | $2,852,054 | September 1, 2024 | August 31, 2025 | PELI, ELI | reporter.nih.gov |
| Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis | NIH | National Eye Institute | 2021 to 2025 | $2,667,355 | December 1, 1984 | August 31, 2027 | CIOLINO, JOSEPH B. | reporter.nih.gov |
| Immunopathogenic Mechanisms of Dry Eye Disease | NIH | National Eye Institute | 2021 to 2025 | $2,528,012 | September 30, 2010 | November 30, 2029 | DANA, REZA | reporter.nih.gov |
| Role of Oxidative Stress in Pathogenesis of Fuchs Endothelial Corneal Dystrophy | NIH | National Eye Institute | 2021 to 2025 | $2,513,809 | July 1, 2010 | July 31, 2029 | JURKUNAS, ULA V. | reporter.nih.gov |
| Fas Ligand Cleavage regulates ocular homeostasis and glaucoma | NIH | National Eye Institute | 2022 to 2025 | $2,452,230 | February 1, 2022 | January 31, 2027 | GREGORY-KSANDER, MEREDITH | reporter.nih.gov |
| Contribution of Mast Cells in Non-Allergic Ocular Inflammation | NIH | National Eye Institute | 2021 to 2025 | $2,432,950 | September 1, 2019 | May 31, 2027 | CHAUHAN, SUNIL K | reporter.nih.gov |
| Humanization of a Notch 3 agonist antibody for pre-clinical development of a CADASIL treatment | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,204,584 | January 15, 2021 | December 31, 2023 | ARBOLEDA-VELASQUEZ, JOSEPH | reporter.nih.gov |
| Investigation of endomucin as a novel regulator of angiogenesis | NIH | National Eye Institute | 2021 to 2024 | $2,044,289 | February 1, 2017 | July 31, 2025 | D'AMORE, PATRICIA ANN | reporter.nih.gov |
| The Impact of Donor Diabetes on Corneal Immune Cells and Graft Survival | NIH | National Eye Institute | 2022 to 2025 | $1,896,125 | September 30, 2022 | August 31, 2027 | DANA, REZA | reporter.nih.gov |
| Conjunctival Goblet Cell Mucin Secretion in Inflammation and Its Resolution | NIH | National Eye Institute | 2021 to 2023 | $1,637,159 | May 1, 2009 | December 31, 2024 | DARTT, DARLENE A | reporter.nih.gov |
| Topical Neurokinin-1 Receptor Antagonist as an Effective Non-addictive Analgesic for Ocular Pain | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,559,917 | August 5, 2024 | July 31, 2026 | DANA, REZA | reporter.nih.gov |
| Humanization of a Notch 3 Agonist Antibody for Pre-Clinical Development of a CADASIL Treatment | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,529,075 | January 15, 2021 | December 31, 2025 | ARBOLEDA-VELASQUEZ, JOSEPH | reporter.nih.gov |
| Mechanisms of immunological memory-mediated pathogenesis in chronic autoimmune uveitis | NIH | National Eye Institute | 2023 to 2025 | $1,477,500 | May 1, 2023 | April 30, 2028 | CHEN, YIHE | reporter.nih.gov |
| Mechanisms of microglial neuroinflammatory response in glaucoma | NIH | National Eye Institute | 2023 to 2025 | $1,403,625 | September 1, 2023 | August 31, 2028 | MARGETA, MILICA | reporter.nih.gov |
| Immune Mechanisms of Chronic Ocular Damage after Acute Exposure to Nitrogen Mustard | NIH | National Eye Institute | 2024 to 2025 | $1,371,293 | September 30, 2024 | August 31, 2027 | CHEN, YIHE | reporter.nih.gov |
| Personalizing Glaucoma Diagnosis by Disease Specific Patterns and Individual Eye Anatomy | NIH | National Eye Institute | 2021 to 2023 | $1,355,167 | September 30, 2019 | July 31, 2025 | ELZE, TOBIAS | reporter.nih.gov |
| Developing Population-Generalizable Deep Learning Models for Automated Glaucoma Screening | NIH | National Eye Institute | 2024 to 2025 | $1,335,321 | September 30, 2024 | July 31, 2029 | WANG, MENGYU | reporter.nih.gov |
| Monocular Visual Confusion for Field Expansion | NIH | National Eye Institute | 2021 to 2023 | $1,303,155 | September 1, 2020 | August 31, 2025 | PELI, ELI | reporter.nih.gov |
| Construction of Conjunctival Equivalents Using Molecular Deposition Techniques | NIH | National Eye Institute | 2021 to 2023 | $1,158,360 | February 1, 2020 | July 31, 2024 | DARTT, DARLENE A | reporter.nih.gov |
| Anesthetic-Eluting Contact Lens for Corneal Pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,120,889 | April 1, 2023 | March 31, 2025 | CIOLINO, JOSEPH B. | reporter.nih.gov |
| Role of Runx1 in Pathologic Ocular Angiogenesis | NIH | National Eye Institute | 2021 to 2022 | $1,030,239 | August 5, 2018 | May 31, 2024 | KIM, LEO A | reporter.nih.gov |
| Protective function of STAT3-mediated astrocyte reactivity in experimental glaucoma: mechanism of action | NIH | National Eye Institute | 2021 to 2022 | $955,450 | September 1, 2018 | May 31, 2023 | SUN, DANIEL | reporter.nih.gov |
| Non-invasive Electrical Stimulation as a Therapy for Diabetic Keratopathy | NIH | National Eye Institute | 2025 | $896,046 | September 1, 2025 | August 31, 2027 | YANG, MENGLU | reporter.nih.gov |
| Training Program in the Molecular Bases of Eye Disease | NIH | National Eye Institute | 2021 to 2025 | $878,004 | February 1, 1997 | June 30, 2028 | D'AMORE, PATRICIA ANN | reporter.nih.gov |
| Relationship between Glaucoma and the Three-Dimensional Optic Nerve Head Related Structure | NIH | National Eye Institute | 2021 to 2023 | $741,462 | February 1, 2021 | January 31, 2024 | WANG, MENGYU | reporter.nih.gov |
| Tissue Hypoxia and Topical Oxygen Therapy in Ocular Mustard Gas Injury | NIH | National Eye Institute | 2023 to 2025 | $740,058 | September 1, 2023 | August 31, 2026 | YIN, JIA | reporter.nih.gov |
| Overcome the barriers of vision care in Africa using smartphones | NIH | National Eye Institute | 2024 to 2025 | $706,103 | September 1, 2022 | June 30, 2027 | LUO, GANG | reporter.nih.gov |
| In vivo epigenetic reprogramming of retinal ganglion cells in aging mice with glaucoma | NIH | National Eye Institute | 2025 | $679,159 | May 1, 2025 | April 30, 2029 | GREGORY-KSANDER, MEREDITH | reporter.nih.gov |
| Characterization and optimization of single dose, thermostable and durable vaccine platform towards increased clinical acceptance | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $668,569 | August 23, 2024 | June 30, 2029 | ZABALETA, NEREA | reporter.nih.gov |
| Optic neuropathy in familial dysautonomia: determination of disease mechanisms and functional rescue. | NIH | National Eye Institute | 2025 | $638,267 | April 1, 2025 | March 31, 2030 | CHEKURI, ANIL K. | reporter.nih.gov |
| Mechanisms underlying mustard gas-induced conjunctival injury and use of lipid mediators as medical countermeasures | NIH | National Eye Institute | 2023 | $583,250 | September 1, 2023 | August 31, 2025 | DARTT, DARLENE A | reporter.nih.gov |
| Personalizing Circumpapillary Retinal Nerve Fiber Layer Thickness Norms for Glaucoma | NIH | National Eye Institute | 2023 | $556,962 | September 30, 2023 | August 31, 2025 | WANG, MENGYU | reporter.nih.gov |
| Histone and DNA methyltransferases in optic nerve regeneration | NIH | National Eye Institute | 2022 to 2023 | $541,750 | May 1, 2022 | April 30, 2024 | CHEN, DONG FENG | reporter.nih.gov |
| The astrocyte transcriptome in age and glaucoma: a comparative study of the optic nerve head, optic nerve proper and corpus callosum | NIH | National Eye Institute | 2022 to 2023 | $541,750 | September 30, 2022 | August 31, 2024 | SUN, DANIEL | reporter.nih.gov |
| The Fibrosis-Immunity Interface in Corneal Transplantation | NIH | National Eye Institute | 2025 | $540,213 | August 1, 2025 | July 31, 2030 | DOHLMAN, THOMAS | reporter.nih.gov |
| Therapeutic Function of alpha-Melanocyte Stimulating Hormone (α-MSH) in Acute Injury and Chronic Degeneration of Corneal Endothelium | NIH | National Eye Institute | 2021 to 2022 | $534,363 | May 1, 2021 | March 31, 2023 | DANA, REZA | reporter.nih.gov |
| Pathogenicity of memory Th17 cells in chronic autoimmune uveitis | NIH | National Eye Institute | 2021 to 2022 | $534,363 | May 1, 2021 | June 30, 2023 | CHEN, YIHE | reporter.nih.gov |
| VRC Inhibiting p38 to Prevent and Restore Corneal Scarring | NIH | National Eye Institute | 2023 to 2024 | $512,202 | September 1, 2023 | August 31, 2025 | CIOLINO, JOSEPH B. | reporter.nih.gov |
| Alloimmune-compatible stem cells for ocular diseases | NIH | National Eye Institute | 2025 | $492,500 | January 1, 2025 | December 31, 2029 | CHAUHAN, SUNIL K | reporter.nih.gov |
| Overcome the barriers of vision care in Africa using smartphones | NIH | National Eye Institute | 2022 to 2023 | $491,822 | September 1, 2022 | June 30, 2024 | LUO, GANG | reporter.nih.gov |
| Anesthetic-Eluting Contact Lens for Corneal Pain | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $347,646 | April 1, 2023 | March 31, 2028 | CIOLINO, JOSEPH B. | reporter.nih.gov |
| Cytoprotective and Pro-regenerative Neuropeptide as Countermeasure to Mustard Gas Ocular Damage | NIH | National Eye Institute | 2025 | $295,500 | September 15, 2025 | August 31, 2027 | CHEN, YIHE | reporter.nih.gov |
| Nanomaterials to improve growth factor delivery to the cornea | NIH | National Eye Institute | 2025 | $260,661 | August 1, 2025 | July 31, 2028 | KANU, LEVI N | reporter.nih.gov |
| Mechanisms of corneal stromal activation during regeneration and fibrosis by exosomes | NIH | National Eye Institute | 2023 to 2024 | $240,170 | September 30, 2023 | August 31, 2025 | YEUNG, VINCENT | reporter.nih.gov |
| Gaze scanning by walking people with visual field loss | NIH | National Eye Institute | 2021 | $238,862 | September 30, 2020 | August 31, 2023 | LUO, GANG | reporter.nih.gov |
| Partial epigenetic reprogramming of retinal pigment cells in age-related degeneration, dysfunction, and injury | NIH | National Eye Institute | 2023 to 2024 | $228,078 | July 1, 2023 | June 30, 2025 | HU, ZHENGPING | reporter.nih.gov |
| Regulating cell-cell interactions to improve donor retinal ganglion cell integration | NIH | National Eye Institute | 2022 to 2024 | $221,530 | February 1, 2022 | January 31, 2025 | SOUCY, JONATHAN R | reporter.nih.gov |
| Mesenchymal Stem Cells can Restore and Maintain Corneal Endothelial Function | NIH | National Eye Institute | 2021 to 2022 | $212,678 | September 1, 2021 | August 31, 2024 | ISLAM, MOHAMMAD MIRAZUL | reporter.nih.gov |
| Sex difference in conjunctival epithelial cell response and their profile of extracellular bioactive lipids duringallergic inflammation | NIH | National Eye Institute | 2023 to 2024 | $146,256 | September 1, 2023 | August 31, 2025 | LEE, CHANGRIM | reporter.nih.gov |
| Generation of suturable artificial cornea from the integration of exfoliated graphene with gelatin glycidyl methacrylate | NIH | National Eye Institute | 2021 to 2022 | $138,849 | April 1, 2022 | March 31, 2023 | SHARIFI, SINA | reporter.nih.gov |
| Regulating host neural activity to improve retinal ganglion cell replacement therapies | NIH | National Eye Institute | 2025 | $132,597 | February 1, 2025 | January 31, 2026 | SOUCY, JONATHAN R | reporter.nih.gov |
| N-Glycosylation and Ocular Surface Homeostasis | NIH | National Eye Institute | 2021 | $113,897 | August 1, 2016 | December 31, 2021 | ARGUESO, PABLO | reporter.nih.gov |
| Understanding Endoplasmic Reticulum-Mitochondrial Cross-Talk in Corneal Endothelial Cells | NIH | National Eye Institute | 2021 | $102,744 | May 1, 2020 | March 31, 2022 | KUMAR, VARUN | reporter.nih.gov |
| 33rd Biennial Cornea Conference | NIH | National Eye Institute | 2024 | $45,000 | August 1, 2024 | July 31, 2025 | JURKUNAS, ULA V. | reporter.nih.gov |
| The 9th Military Vision Symposium on Novel Technology and Vision Restoration. | NIH | National Eye Institute | 2025 | $45,000 | January 1, 2025 | December 31, 2025 | CHEN, DONG FENG | reporter.nih.gov |
| The 7th Military Vision Symposium on Ocular Readiness for Military Conflicts and Civilian Casualties | NIH | National Eye Institute | 2021 | $40,000 | January 1, 2021 | June 30, 2023 | CHEN, DONG FENG | reporter.nih.gov |
| 7th Biennial Symposium on AMD | NIH | National Eye Institute | 2025 | $40,000 | September 1, 2025 | August 31, 2026 | D'AMORE, PATRICIA ANN | reporter.nih.gov |
| 32nd Biennial Cornea Conference | NIH | National Eye Institute | 2022 | $25,000 | September 1, 2022 | August 31, 2023 | GIPSON, ILENE K. | reporter.nih.gov |
| Regulation of the immune cell glycome in corneal injury | NIH | National Eye Institute | 2021 | $1 | September 1, 2020 | December 31, 2021 | ARGUESO, PABLO | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 29 | $14,900,716 | 0 | $0 |
| 2024 | 29 | $14,522,821 | 0 | $0 |
| 2023 | 33 | $15,771,644 | 0 | $0 |
| 2022 | 29 | $12,799,447 | 0 | $0 |
| 2021 | 29 | $13,652,035 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Eye Disease and Disorders of Vision
- Neurosciences
- Neurodegenerative
- Clinical Research
- Aging
- Bioengineering
- Regenerative Medicine
- Transplantation
- Genetics
- Wound Healing and Care
- Prevention
- Biotechnology
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.